PL
MEDP icon

Pluribus Labs’s Medpace MEDP Stock Holding History

Pluribus Labs’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,286
Closed -$280K – 162
2021
Q4 		$280K Buy
+1,286
New +$269K 0.3% 144

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
ESCM
Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VVP
Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pluribus Labs's MEDP Position: Q1 2022 in Review

Pluribus Labs sold out of Medpace (MEDP) in Q1 2022, closing a stake of 1,286 shares — an estimated $280K sold.

Pluribus Labs first reported a position in MEDP in Q4 2021 and held it in 1 quarter. The position peaked at $280K in Q4 2021. 349 funds tracked by Wall St. Rank hold MEDP as of Q1 2022.

  • Pluribus Labs reported no remaining Medpace position as of Q1 2022 after selling out during the quarter.
  • Pluribus Labs sold 1,286 Medpace shares in Q1 2022, an estimated $280K.
  • Pluribus Labs first reported a position in Medpace in Q4 2021 and held it in 1 quarter.
  • Pluribus Labs's Medpace position peaked at $280K in Q4 2021.
  • 349 funds tracked by Wall St. Rank held Medpace as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.